Flexion reports plans to sell 3.5 million common shares in public sale

BMO, RBC, Needham, Janney Montgomery Scott and Summer Street to assist

By Devika Patel

Knoxville, Tenn., Dec. 8 – Flexion Therapeutics Inc. will offer 3.5 million common shares in a public offering with a greenshoe of 525,000 additional shares, according to a Form S-1/A filed Monday with the Securities and Exchange Commission.

BMO Capital Markets and RBC Capital Markets are the bookrunners; Needham & Co., Janney Montgomery Scott and Summer Street Research Partners are the co-managers.

Proceeds will be used for product development, sales and marketing, clinical studies and general working capital purposes.

The Burlington, Mass., specialty pharmaceutical company develops injectable pain therapies.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.